New antituberculous drug

Descripción del Articulo

Tuberculosis (TB) is a communicable disease that is still a very important health problem in the 21st Century, and it is currently threatening mankind with the emergence of new multidrug resistant (MDR) and extremely resistant (XDR) strains of its causative agent, Mycobacterium tuberculosis. In this...

Descripción completa

Detalles Bibliográficos
Autor: Bayona García, Jaime
Formato: artículo
Fecha de Publicación:2009
Institución:Colegio Médico del Perú
Repositorio:Acta Médica Peruana
Lenguaje:español
OAI Identifier:oai:ojs.pkp.sfu.ca:article/1536
Enlace del recurso:https://amp.cmp.org.pe/index.php/AMP/article/view/1536
Nivel de acceso:acceso abierto
Materia:Drugs
Tuberculosis
TB
Antituberculous
id REVCMP_72fa2175b590328c0c6e09b28d619db6
oai_identifier_str oai:ojs.pkp.sfu.ca:article/1536
network_acronym_str REVCMP
network_name_str Acta Médica Peruana
repository_id_str .
spelling New antituberculous drugNuevos fármacos antituberculososBayona García, JaimeDrugsTuberculosisTBAntituberculousTuberculosis (TB) is a communicable disease that is still a very important health problem in the 21st Century, and it is currently threatening mankind with the emergence of new multidrug resistant (MDR) and extremely resistant (XDR) strains of its causative agent, Mycobacterium tuberculosis. In this scenario, there are very few new antituberculous drugs developed by the pharmaceutical industry, so the therapeutic strategy for this old disease has not undergone substantial changes. Nowadays, every human being is at risk for exposure and for acquiring tuberculosis, so that people acquiring the disease may be exposed to a prolonged therapy schedule, or they may even face death because of lack of effectiveness of antituberculous drugs in MDR or XDR TB cases.La tuberculosis es una enfermedad infectocontagiosa que en pleno siglo XXI continúa siendo un flagelo mundial y que amenza a la humanidad con nuevas formas emergentes de tuberculosis multidrogo resistente (MDR) y la extremadamente resistente a todos los medicamenteos conocidos, la tuberculosis XDR. En este contexto son pocos los nuevos mediamentos antituberculosos desarrollados por la industria farmaceútica, por lo que el esquema terapéutico contra esta antigua enfermedad no ha variado sustancialmente. Hoy todos los seres humanos estamos expuestos y en peligro de contagiarnos de tuberculosis y por ende tener que iniciar prolongados tratamientos o tal vez enfrentar la muerte por falta de acción efectiva de éstos contra el germen productor de la tuberculosis.Colegio Médico del Perú2009-09-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://amp.cmp.org.pe/index.php/AMP/article/view/1536ACTA MEDICA PERUANA; Vol 26 No 4 (2009); 247 - 250ACTA MEDICA PERUANA; Vol. 26 Núm. 4 (2009); 247 - 2501728-59171018-8800reponame:Acta Médica Peruanainstname:Colegio Médico del Perúinstacron:CMPspahttps://amp.cmp.org.pe/index.php/AMP/article/view/1536/968Copyright (c) 2020 ACTA MEDICA PERUANAinfo:eu-repo/semantics/openAccessoai:ojs.pkp.sfu.ca:article/15362023-07-06T06:01:31Z
dc.title.none.fl_str_mv New antituberculous drug
Nuevos fármacos antituberculosos
title New antituberculous drug
spellingShingle New antituberculous drug
Bayona García, Jaime
Drugs
Tuberculosis
TB
Antituberculous
title_short New antituberculous drug
title_full New antituberculous drug
title_fullStr New antituberculous drug
title_full_unstemmed New antituberculous drug
title_sort New antituberculous drug
dc.creator.none.fl_str_mv Bayona García, Jaime
author Bayona García, Jaime
author_facet Bayona García, Jaime
author_role author
dc.subject.none.fl_str_mv Drugs
Tuberculosis
TB
Antituberculous
topic Drugs
Tuberculosis
TB
Antituberculous
description Tuberculosis (TB) is a communicable disease that is still a very important health problem in the 21st Century, and it is currently threatening mankind with the emergence of new multidrug resistant (MDR) and extremely resistant (XDR) strains of its causative agent, Mycobacterium tuberculosis. In this scenario, there are very few new antituberculous drugs developed by the pharmaceutical industry, so the therapeutic strategy for this old disease has not undergone substantial changes. Nowadays, every human being is at risk for exposure and for acquiring tuberculosis, so that people acquiring the disease may be exposed to a prolonged therapy schedule, or they may even face death because of lack of effectiveness of antituberculous drugs in MDR or XDR TB cases.
publishDate 2009
dc.date.none.fl_str_mv 2009-09-29
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/1536
url https://amp.cmp.org.pe/index.php/AMP/article/view/1536
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/1536/968
dc.rights.none.fl_str_mv Copyright (c) 2020 ACTA MEDICA PERUANA
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2020 ACTA MEDICA PERUANA
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Colegio Médico del Perú
publisher.none.fl_str_mv Colegio Médico del Perú
dc.source.none.fl_str_mv ACTA MEDICA PERUANA; Vol 26 No 4 (2009); 247 - 250
ACTA MEDICA PERUANA; Vol. 26 Núm. 4 (2009); 247 - 250
1728-5917
1018-8800
reponame:Acta Médica Peruana
instname:Colegio Médico del Perú
instacron:CMP
instname_str Colegio Médico del Perú
instacron_str CMP
institution CMP
reponame_str Acta Médica Peruana
collection Acta Médica Peruana
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1816075108237705216
score 13.95948
New antituberculous drug
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).

Ejemplares Similares